Psychometric evaluations were performed on a self-perceived localization disabilities and handicaps questionnaire. Twenty individuals with normal hearing bilaterally, twenty with profound unilateral hearing impairment (UHI), and ten with any degree of bilateral hearing impairment participated. Each subject completed the questionnaire. Comparisons of the responses of the subjects with normal hearing and those with UHI revealed significant differences among the groups for both disabilities and handicaps, establishing construct validity. Cronbach's Alpha correlational analyses of the responses of all subjects with hearing impairment revealed correlations of .900 (disabilities) and .800 (handicaps), establishing internal consistency. Each participant with hearing impairment was asked to complete the questionnaire again after three weeks. Pearson's correlational analyses of the responses at time one versus time two revealed correlations of .900 (disabilities) and .700 (handicaps), establishing test/retest reliability. This questionnaire is an appropriate tool for investigating the self-perceived localization disabilities and handicaps of individuals with hearing impairment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3766/jaaa.16.8.7 | DOI Listing |
Optom Vis Sci
January 2025
University of Queensland Centre for Hearing Research (CHEAR), School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Queensland, Australia.
Background: The prevalence of visual impairment among individuals living in long-term care (LTC) is substantial, yet eye care is often disregarded and inadequately addressed. This neglect contributes to a decline in quality of life for residents. Thus, understanding the challenges faced by stakeholders in providing eye care for residents might suggest opportunities to improve eye health outcomes.
View Article and Find Full Text PDFCan Assoc Radiol J
January 2025
North York General Hospital, Toronto, ON, Canada.
The Canadian Association of Radiologists (CAR) Central Nervous System Expert Panel is made up of physicians from the disciplines of radiology, emergency medicine, neurosurgery, and neurology, a patient advisor, and an epidemiologist/guideline methodologist. After developing a list of 24 clinical/diagnostic scenarios, a rapid scoping review was undertaken to identify systematically produced referral guidelines that provide recommendations for one or more of these clinical/diagnostic scenarios. Recommendations from 55 guidelines and contextualization criteria in the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) for guidelines framework were used to develop 51 recommendation statements across the 24 scenarios.
View Article and Find Full Text PDFFront Public Health
January 2025
College of Physical Education and Health, Guangxi Normal University, Guilin, China.
Objective: This study aims to assess the relationship between modifiable dementia risk factors and both dementia and cognitive decline.
Methods: Data were obtained from the Health and Retirement Study (HRS) [2008-2020], the China Health and Retirement Longitudinal Study (CHARLS) [2011-2020], and the English Longitudinal Study of Ageing (ELSA) [2010-2020]. After adjusting for confounding factors, multivariable logistic regression was utilized to analyze the relationship between modifiable dementia risk factors and dementia, while multivariable linear regression was employed to examine the relationship between these risk factors and cognitive decline.
Front Pharmacol
January 2025
College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, Jilin, China.
Introduction: Cisplatin is extensively employed in the treatment of multiple solid malignant tumors. Nevertheless, side effects such as cisplatin-induced ototoxicity (CIO) pose obstacles to tumor therapy.The important natural product chiisanoside from has abundant activity against CIO.
View Article and Find Full Text PDFJ Neurol Surg B Skull Base
February 2025
Department of Neurosurgery, UC San Diego Medical Center, San Diego, California, United States.
Many patients with neurofibromatosis type 2 (NF2) suffer from sensorineural hearing loss, and associated cochlear nerve compromise in NF2 patients makes auditory brainstem implant (ABI) an attractive treatment option. The long-term outcomes and benefits of the device are still being explored. A retrospective review was conducted for 11 ABI recipients at a single-institution tertiary center between November 2017 and August 2022.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!